Showing 1 - 10 of 1,476
Persistent link: https://www.econbiz.de/10011765364
Persistent link: https://www.econbiz.de/10011765425
This paper attempts to evaluate the possible gains and losses arising from the gradual opening up of pharmaceutical trade between India and Pakistan. We explain the comparative advantages of both countries at a disaggregated level, followed by a qualitative analysis of various perceptions and...
Persistent link: https://www.econbiz.de/10010460866
Persistent link: https://www.econbiz.de/10012803543
Persistent link: https://www.econbiz.de/10012029189
Persistent link: https://www.econbiz.de/10011765417
Persistent link: https://www.econbiz.de/10000783327
Persistent link: https://www.econbiz.de/10003592638
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
With the ongoing trade normalisation process between India and Pakistan, opportunities to integrate have opened up between both countries. The pharmaceutical sector is crucial to health issues in developing economies and would be an ideal segment to focus on in improving trade relations between...
Persistent link: https://www.econbiz.de/10010404687